Upload
ngohanh
View
214
Download
0
Embed Size (px)
Citation preview
Infection and Immunity in Autism Spectrum DisordersNew Tools for Pathogen Discovery
18-19 April 2007Institute of Medicine
Washington, DC
W. Ian LipkinColumbia University and the Northeast Biodefense Center
NIAID, NINDS, NHLBI, NEI, DOD, CAN
PANDORA’S BOX PROJECT
MECHANISMS OF MICROBIAL PATHOGENESISPart I
Direct effects at infection sitereplication causes cell damagePoliovirusMotor neurons are killed, causing paralysis
toxin alters local physiologyVibrio choleracholera toxin alters ion transport in intestine, causing diarrhea
Effects distal to infection sitemicrobe produces a toxin with distant effectClostridium botulinumBotulinum toxin interferes with neurotransmitter function at nerve-muscle junction
Host responses influence outcomes
host response to microbe causes or augments damage at infection siteHepatitis BImmune response kills infected liver cells
microbe causes immunosuppression, increasing susceptibility to other agentsMeasles virus, HIVExacerbation of tuberculosis; opportunistic infections
Effects depend on maturational status of host organ systems at time of infection
microbe may be teratogenic depending on gestational periodRubella virusFirst trimester congenital infection results in a spectrum of birth defects
MECHANISMS OF MICROBIAL PATHOGENESISPart II
Effects depend on complex pathogen:host interactionsInterference with differentiated cell functionLymphocytic choriomeningitis viruspersistent viral infection alters neurotransmitter or hormone production without killing cells (dementia, diabetes, hypothyroidism)
Molecular mimicryStreptococcusantibodies to bacteria also bind to host, causing cardiac or CNS damage (autoimmunity)
Longterm effects of infection?Multiple sclerosislatitude where one lives before puberty determines risk for a disease that begins in early adulthood
Psychiatric disordersGestational exposure increases risk for schizophrenia, a disorder that first manifests in adolescence or early adulthood
MECHANISMS OF MICROBIAL PATHOGENESISPart III
Emerging Microbial Concepts:Infectious Causes of Chronic Disease
DiseaseCervical CAChronic Hepatitis/HepatocarcinomaLyme ArthritisPeptic Ulcer DiseaseWhipple DiseaseBladder CAPremature BirthCerebral Palsy
CauseHuman papilloma virusHepatitis B and C virusesBorrelia burgdorferiHelicobacter pyloriTropheryma whippeliiSchistosoma haematobiumVariousVarious
Compelling evidence
Emerging Microbial Concepts:Chronic Diseases Potentially Linked to Infection
DiseaseCardio/Cerebrovascular DiseaseDiabetes MellitusObsessive Compulsive Disorder(PANDAS)SchizophreniaInflammatory Bowel DiseaseIdiopathic Pulmonary FibrosisAutismAcute Macular Degeneration
CauseDental/sinus infectionsEnteroviruses, other virusesGroup A streptococcus
Influenza virus????
INTERPLAY OF GENETIC CONTEXT AND TIMING OF ENVIRONMENTAL INSULTS ON PATHOGENESIS
Fetus(a la da Vinci)
Stage 1Week 1
FERTILIZEDOOCYTE
Stage 10Week 4
NEURALFOLD
FUSES
ENVIRONMENTALFACTORS
GENETICFACTORS
DevelopmentalDisorders(Autism)
child
earlyadult
lateadult
Psychiatric & DemyelinatingDisorders (MS)
Degenerativedisorders
Toxins: thalidomide, valproic acid, HgMaternal infection: rubella, influenza (polyIC) Hornig, 2000
A Staged Strategy for Pathogen Discovery
UncharacterizedSample
MassTag PCR• Respiratory disease • Hemorrhagic fevers • Meningoencephalitides• Poxviruses $15/assay, 96 samples in 6 Hours
QuantitativeReal-Time PCR
Consensus PCRCloning & Sequencing
GreeneChips• Viral• Pan-pathogen • Respiratory$75/assay, 8 samples in 15 hrs
Shotgun Sequencing$5,000/assay – 1 week
A STAGED STRATEGY FOR PATHOGEN DETECTION
MassTag PCR
Clinical specimenClinical specimen
Short candidate list<30 agents
New technology for sensitive, highly multiplexed, rapid differential diagnosis of:
Respiratory Infections Meningitides/EncephalitidesHemorrhagic Fevers Gastroenteritides/Diarrheas
Rhinovirus NY (Human rhinovirus C vs Human Enterovirus E)Discovery of a novel virus associated with influenza like illness
HRV NY041
HRV A039
H. influenzae
S. pneumoniae
HPIV-1037
HRV034
M. pneumoniae030
HRV NY028
HRV A026
M. pneumoniae025
HMPV017
S. pneumoniae
HMPV016
HCoV-OC43009
S. pneumoniae004
HRV NY003
AgentSample
HRV B077
HRV NY074
M. pneumoniae072
HRSV-B071
HCoV-OC43070
S. pneumoniae
HRV NY063
M. pneumoniae061
S. pneumoniae
HRV NY060
H. influenzae056
HEV052
S. pneumoniae050
H. influenzae
S. pneumoniae
HRV B045
HRV NY042
S. pneumoniae
FLUBV
FLUAV1140
N. meningiditis
FLUAV1135
HRV
FLUAV1126
S. pneumoniae
FLUBV1119
HRV
FLUAV1101
HSV
HRV NY1085
HRV B
FLUBV1083
S. pneumoniae
HEV
FLUBV1081
Pathogens in Flu-Negative SpecimensAdditional Pathogens inFlu-Positive Specimens
Lamson (2006) J Infectious Dis 194: 1398-1402
Global Distribution of a “New” VirusHuman Enterovirus E vs Human Rhinovirus C
HRV group A
HRV group BEV
New Clade
A STAGED STRATEGY FOR PATHOGEN DETECTION
Clinical specimenClinical specimen
Long candidate list
GreeneChipsHighly multiplexed, differential diagnosis of infectious disease
Virus surveillance Respiratory pathogens; influenza serotyping GreeneChipVr1.5 GreeneChipResp
Virus discoveryGreeneChipVr2.0
Greene Pathogen DatabaseComprehensive, curated database of pathogen sequences
WHO Outbreak Surveillance Differential diagnosis of hemorrhagic fever
Clinical Specimen DNA
Random primed PCR Secondary PCR to incorporateshort DNA tag
Hybridize unlabeled templatein multi-well slides
Secondary hybridization to incorporate 3DNA flourophore
GreeneChip Protocols
Agilent arrays• In situ synthesis• High density/multiplex format• Rapid modification
NCBI Sequence data (Nat. Center for Biotechnology Information)
ICTVdB (Int.Comittee on Taxonomy of Viruses)
Pfam database(Protein FamiIies)
Viral sequence database382,512
Greene Pathogen Databases
RDP (Ribosomal Database Project)
+NCBI
Pan-microbial sequence database382,512 viruses
41,790 bacteria 4,109 fungus2,626 parasites
ExperimentDatabase
PI, affiliation, clinical,geography, results, comments
H5N1
Web-based Analysis of GreeneChip DataAccounts: Australian Biosecurity CRC (Boyle); CDC (Nichol & Towner); Stanford
(Hirschberg & Davis); Institut Pasteur Shanghai (Deubel); Univ of Colorado(Holmes & Dominguez); Wadsworth Center,NYSDOH (St. George & Dean)
Enteroviruses in Feces of Healthy Norwegian Children Aged 3-28 Months (145 of 1,255 samples)
2.43HEVUntyped
1.62CAV19HEV-C
1.62HEV-BaHEV-B
0.81EV30HEV-B
0.81EV25HEV-B
8.911EV18HEV-B
1.62EV13HEV-B
0.81EV11HEV-B
2.43EV9HEV-B
0.81EV5HEV-B
1.62EV3HEV-B
3.24CBV5HEV-B
2.43CBV4HEV-B
7.39CBV3HEV-B
4.05CBV1HEV-B
3.24CAV9HEV-B
3.24HEV-AaHEV-A
14.518HEV71HEV-A
0.81CAV16HEV-A
4.86CAV14HEV-A
5.67CAV10HEV-A
10.513CAV6HEV-A
5.67CAV5HEV-A
8.911CAV4HEV-A
2.43CAV2HEV-A
Percent (n=124)EpisodesSerotypeSpecies
5’ UTR mutationsmay inhibit EVfitness
A STAGED STRATEGY FOR PATHOGEN DETECTION
Hi Throughput Sequencing
Disclosure454 Life Sciences Scientific Advisory Board 2003-present
Novel high throughput pyrosequencing slide-based platformAlgorithm for Reductive Analysis of Sequence DataProgram for automated identification of pathogen sequences
Outbreak of Transplant-Associated Encephalitis Identification of a novel arenavirus
Colony Collapse Disorder Profile of an emerging threat to agriculture and economic welfare
Primer
Repeat
Trimming FilteringClustering Assembly
Raw Reads
host
ContigsTrimmed Reads Unique Reads Non-host ReadsReductive Analysis of Highthroughput Sequencing Data
Contigs and SingletsContigs and Singlets
Candidates withNucleotide Homology
Candidates withNucleotide Homology
BLASTN
Candidates withProtein HomologyCandidates with
Protein Homology
BLASTX
viruses
bacteria
fungi
metazoans
parasites
Sequence ð TaxonomySequence ð Taxonomy
Candidate organism
High Throughput Sequencing in Pathogen Surveillance and Discovery
Encephalitis MassTag PCR
140,000 sequences obtained
14 (0.01%) Old World Arenavirus sequences
S-segmentGreeneChipVr1.5 array
High throughput sequencing of pooledrandom PCR products
2007: 3 cases of transplant associated disease Organ Donor: 57 y/o M (thalamic bleed)
Recipients: 63 y/o F (kidney), 44 y/o F (kidney), 64 y/o F (liver)
• S-segment, 12 sequences• L-segment, 2 sequences
Identical sequence in donor and recipients
50,000 RNA copies in liver and kidney<100 RNA copies in brain and serum
To Bee or Not to Bee…Colony Collapse Disorder
Global pollination of > 90 fruit and vegetable crops$14.6B/year in US alone
Family apoidea
AlfalfaAlmondAppleApricot (some varieties)ArtichokeAvocadoBlackberryBlack locustBlueberryBoysenberryBroadbeansBroccoliBrussels sproutsBuckwheatCabbageCarawayCarrotsCatalpaCauliflowerCeleryCherryChestnutChicoryChinese cabbage
Clover (some varieties)CoconutCoffeeCollardsCorianderCottonCrabappleCranberriesCrownvetchCucumbersCurrantsDewberryDillEggplantEndiveFennelFigsFlaxGarlicGooseberriesGrapes (muscadine)GrapefruitGuarGuava
Holly KaleKenafKiwiKohlrabiLeekLespedeza (bush)Lima beansLoquatsMacadamia nutMaple (red)Mandarin orangeMangoMuskmelonsMustardNectarinesOkra OnionsOrange PapayaParsleyParsnipsPeachesPear
Pepper Persimmon (native)Plums and PrunePumpkinsRadishRapeRaspberryRutabagaSafflower SquashStrawberrySunflowerSweetcloverTangeloTangerineTendergreensTrefoilTurnipsVetchWatermelonsYucca
viruses
bacteria
fungi
metazoans
parasites
Varroa destructor mite
Kynetoplastide parasite species
Nosema sp.
Neisseria species
Gamma proteobacteria
Viruses
ssRNA (+)
Dicistroviridae
Cripavirus
Black Queen Virus
Israel acute paralysis virus
Kashmir bee virus
Iflavirus
Sacbrood virus
Deformed wing virus
Chronic bee paralysis virus
Large unselected cohort (100,000)
Prospective collections of clinical data and biologic specimens begins early in gestationBiological and clinical phenotypes Longitudinal trajectory of diseaseFunctional genomics, proteomics, toxicology, as well as genetics
Resources establishedClinical databases (questionnaires, videography, clinical exams, outcomes)Biobanks of unique clinical materials
Maternal blood during pregnancy and at termPaternal bloodCord blood
Autism Birth CohortGENE X ENVIRONMENT X TIMING INTERACTIONS IN DISEASE
UO1-NS047537
www.abc.columbia.edu
Summary
Microbial pathogenesis is complex• Susceptibility is a function of genes, age, other factors• Mechanisms can be direct, indirect• Expression of disease may be delayed
The microbiome is largely uncharted.
The advent of new tools for microbial surveillance canchange the landscape of chronic as well as acute diseases.
Realization of the promise of these tools will require aninvestment not dissimilar to that allocated for genetics.